Clinical Trial Update: Halaven Patient Registry (Metastatic Breast Cancer, MBC)

View source ↗

Summary

A clinical trial registry update for the Halaven (eribulin mesylate) patient registry in metastatic and advanced breast cancer, sponsored by Chang Gung Memorial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Halaven (eribulin)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Metastatic Breast Cancer, Advanced Breast Cancer | Status: UNKNOWN